A Moscow-based programme offering autologous haematopoietic stem cell transplantation for autoimmune diseases, led by a named consultant haematologist.
HSCT Russia presents itself as a treatment programme in Moscow built around autologous haematopoietic stem cell transplantation, a procedure in which a patient's own blood-forming stem cells are collected, the immune system is suppressed with chemotherapy, and the stored cells are returned to rebuild it. The site says the programme is directed at autoimmune disease rather than at cancer, with multiple sclerosis its principal indication.
According to the site, applications are reviewed personally by Dr Denis Fedorenko, whom it describes as a doctor of medical sciences and a professor in a department of haematology and cellular therapy, and the author of more than 250 publications. It lists membership of the European Society for Blood and Marrow Transplantation, the American Society of Hematology and the European Hematology Association. Prospective patients are asked to complete a medical questionnaire, which is then assessed to decide whether transplantation is appropriate.
The site states that the programme has twenty years of experience, has treated more than 3,000 patients and draws patients from more than 70 countries. It also advertises efficacy figures of between 75 and 95 per cent for stabilising multiple sclerosis. These are the clinic's own marketing claims, they are not independently verified, and readers should treat published percentages of this kind with caution and discuss them with their own neurologist.
Practical arrangements described on the site include pre-transplant examination, coordination of admission, visa assistance for international patients, follow-up programmes after discharge, and patient forums and webinars. The site does not publish a street address, a direct telephone number or a price list; cost and treatment duration are given only after the questionnaire has been reviewed.
The site lists the following autoimmune conditions among those it considers for transplantation.
The site says it uses autologous, meaning from the patient's own body, haematopoietic stem cells, which are blood-forming cells collected before conditioning chemotherapy and returned afterwards.
The site names one clinician as leading the programme.
The site says treatment is delivered in Moscow within a department of a large multidisciplinary medical and surgical centre, and refers to hospital licences without displaying them on the pages read. It does not publish a street address, a telephone number, photographs of the wards or details of bed numbers, which is a real gap for anyone trying to confirm where they would be treated. Contact is made through an online application form rather than a listed clinic address.
The site does not publish prices. It states that the cost and the length of treatment are given only after a medical questionnaire has been submitted and reviewed.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.